This report is a description of this rare presentation
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Clinically isolated syndrome (CIS) and multiple sclerosis are autoimmune diseases of the central nervous system that are characterized by inflammation, demyelination, and axonal damage.
📊
Key Findings & Data:Malaria can also demonstrate neurological symptoms and develop into cerebral malaria, which can lead to severe neurological disability.
💡
Conclusion & Impact:This report is a description of this rare presentation
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Clinically isolated syndrome (CIS) and multiple sclerosis are autoimmune diseases of the central nervous system that are characterized by inflammation, demyelination, and axonal damage. Clinical symptoms can be aggravated by fever or concomitant infection. Malaria can also demonstrate neurological symptoms and develop into cerebral malaria, which can lead to severe neurological disability. The present patient had a diagnosis of Plasmodium vivax infection and displayed neurological symptoms and fever. After exclusion of cerebral malaria and other infectious diseases, the patient had a final diagnosis of CIS and the appropriate treatment was initiated. This report is a description of this rare presentation
🔖
Cite This Article
KILIÇ, A. K., AK, Ö., YAKIN, M., NADİR, Y., ÖZER, S. (2017). Plasmodium Vivax-Precipitated Neurological Symptoms: Central Nervous System Idiopathic Inflammatory Demyelinating Disease/Multiple Sclerosis. Southern Clinics of Istanbul Eurasia, Cilt: 28 - Sayı: 3, 237–240. https://ajindex.com/articles/314106
Thouvenot É. Update on clinically isolated syndrome. Presse Med 2015;44:e121–36
Popescu BF, Pirko I, Lucchinetti CF. Pathology of multiple sclerosis: where do we stand? Continuum (Minneap Minn) 2013;19:901–21
Thrower BW. Relapse management in multiple sclerosis. Neurologist 2009;15:1–5
WHO. World Malaria Report 2015. Geneva: World Health Organization; 2015. p. 280
Manning L, Laman M, Law I, Bona C, Aipit S, Teine D, et al. Features and prognosis of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed Plasmodium species in Papua New Guinean children. PLoS One 2011;6:e29203
Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000;94 Suppl 1:S1–90
Idro R, Marsh K, John CC, Newton CR. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res 2010;68:267–74
Mani S, Mondal SS, Guha G, Gangopadhyay S, Pani A, Das Baksi S, et al. Acute disseminated encephalomyelitis after mixed malaria infection (Plasmodium falciparum and Plasmodium vivax) with MRI closely simulating multiple sclerosis. Neurologist 2011;17:276–8
Sotgiu S, Angius A, Embry A, Rosati G, Musumeci S. Hygiene hypothesis: innate immunity, malaria and multiple sclerosis. Med Hypotheses 2008;70:819–25
Wirz SA, Morale MC, Marchetti B, Barr AM, Sotgiu S, Rosati G, et al. High frequency of TNF alleles -238A and -376A in individuals from northern Sardinia. Cytokine 2004;26:149–54
Sotgiu S, Sannella AR, Conti B, Arru G, Fois ML, Sanna A, et al. Multiple sclerosis and anti-Plasmodium falciparum innate immune response. J Neuroimmunol 2007;185:201–7
Correale J, Fiol M, Gilmore W. The risk of relapses in multiple sclerosis during systemic infections. Neurology 2006;67:652–9.